Back to mobile site

Incyte (INCY): Thoughts From BMS-986205 Trial Data - BMO

November 13, 2017 6:32 AM EST Send to a Friend
BMO Capital analyst, Ian Somaiya, reiterated his Outperform rating on shares of Incyte (NASDAQ: INCY) and expects shares to start ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login